Drug insight: Anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation (Q36749766)

16 August 2017

1 reference

title

Drug insight: Anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation (English)

1 reference

16 August 2017

6

Olav Spigset

1 reference

16 August 2017

7

Tore K Kvien

1 reference

16 August 2017

Johan F Skomsvoll

1

1 reference

16 August 2017

Marianne Wallenius

2

1 reference

16 August 2017

Hege S Koksvik

3

1 reference

16 August 2017

Erik Rødevand

4

1 reference

16 August 2017

Kjell A Salvesen

5

1 reference

16 August 2017

publication date

1 March 2007

1 reference

Nature Clinical Practice Rheumatology

16 August 2017

published in

1 reference

16 August 2017

volume

3

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

156-164

1 reference

The Effect of Pregnancy on Ankylosing Spondylitis, Psoriatic Arthritis, and Juvenile Rheumatoid Arthritis

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

Cytokine pathways and joint inflammation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Biological functions of tumor necrosis factor cytokines and their receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

TNF-alpha in pregnancy loss and embryo maldevelopment: a mediator of detrimental stimuli or a protector of the fetoplacental unit?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

TH1/TH2,3 imbalance due to cytokine-producing NK, gammadelta T and NK-gammadelta T cells in murine pregnancy decidua in success or failure of pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Adalimumab and methotrexate is more effective than adalimumab alone in patients with established rheumatoid arthritis: results from a 6-month longitudinal, observational, multicentre study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Pregnancy and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Disease activity and pregnancy associated alpha 2-glycoprotein in rheumatoid arthritis during pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Does rheumatoid arthritis remit during pregnancy and relapse postpartum?: Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Cytokines and pregnancy in rheumatic disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Pregnancy and rheumatic disease. A review of recent studies in rheumatoid arthritis and ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Pregnancy in patients with a history of juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Pregnancy outcome in women who were exposed to anti–tumor necrosis factor agents: Results from a national population register

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Using an analogous monoclonal antibody to evaluate the reproductive and chronic toxicity potential for a humanized anti-TNFalpha monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Infliximab treatment and pregnancy outcome in active Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Adalimumab use in pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

The effects of methotrexate on pregnancy, fertility and lactation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Infliximab may reverse the toxic effects induced by tumor necrosis factor alpha in human spermatozoa: an in vitro model

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Effect of tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on human sperm motility, viability and motion parameters

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Relationship between seminal plasma interleukin-6 and tumor necrosis factor alpha levels with semen parameters in fertile and infertile men

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Absence of a direct effect of recombinant tumor necrosis factor-alpha on human sperm function and murine preimplantation development

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

Acute effects of tumor necrosis factor-alpha on testicular germ cell apoptosis and vascular neutrophil adhesion in rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0426

7 January 2021

https://api.fatcat.wiki/v0/release/mw6geb7gorf7dk4xqtw7r4dkcy

Identifiers

1 reference

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_mw6geb7gorf7dk4xqtw7r4dkcy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mw6geb7gorf7dk4xqtw7r4dkcy

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/mw6geb7gorf7dk4xqtw7r4dkcy

1 reference

30 July 2022